Spezifische Antiarrhythmika für spezifische Arrhythmien

  • R. W. F. Campbell
Conference paper


Die Diagnose einer Arrhythmie und die Auswahl einer geeigneten Therapie stellen wichtige Aspekte der kardiologischen Praxis dar. Es wäre nicht unvernünftig anzunehmen, daß es für jede spezifische Form der Arrhythmie eine spezielle Behandlung gibt, aber in Wirklichkeit sind diese klinischen Situationen selten. Das mag auf ungenügender Diagnose der Arrhythmie, auf ungenügender Therapie oder auf dem Unvermögen, Spezifität zu erkennen, beruhen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arnsdorf MF (1977) Membrane factors in arrhythmogenesis: concepts and definitions. Prog Cardiovasc Dis 19: 413–429PubMedCrossRefGoogle Scholar
  2. Campbell RWF (1981) Evaluation of antiarrhythmic drugs. Should the Lown classification be used as a measure of efficacy? In: Morganroth J, Moore EN, Dreifus LS, Michelson EL (eds) The evaluation of new antiarrhythmic drugs. Nijhoff, The Hague pp 113–121Google Scholar
  3. Campbell RWF, Achuff SC, Pottage A, Murray A, Prescott LF, Julian DG (1979) Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocaridal infarction. J Cardio Pharm 1: 43–52CrossRefGoogle Scholar
  4. Campbell RWF, Bryson LG, Bailey BJ, Murray A, Julian DG (1981). Prophylactic administration of tocainide in acute myocardial infarction. Workshop on Tocainide, pp 201–204Google Scholar
  5. Corr PB, Sobel BE (1979) The importance of metabolites in the genesis of ventricular dysrhythmia induced by ischemia. Mod Concepts Cardiovasc Dis 48: 49–52PubMedGoogle Scholar
  6. Coumel P, Fidelle J, Lucet V, Attuel P, Bouvrain Y (1978) Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br Heart J [Suppl] 40: 28–37Google Scholar
  7. Editorial (1980) Torsades de Eointes. Eur Heart J 1: 70–71Google Scholar
  8. Editorial Comment (1982) Long-term and short-term beta-blockade after myocardial infarction. Lancet 1:1159–1161Google Scholar
  9. El-Sherif N, Scherlag BJ, Lazzara R, Hope RR (1977) Re-entrant ventricular arrhythmias in the late myocardial infarctioii period. Circulation 56: 395–402PubMedGoogle Scholar
  10. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP (1981) Amiodarone: Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 305: 539–544PubMedCrossRefGoogle Scholar
  11. Josephson ME, Horowitz LN, Farshidi A, Kastor JA (1978) Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation 57: 431–447PubMedGoogle Scholar
  12. Kaski JC, Girotti LA, Messuti H, Rutitzky B, Rosenbaum MB (1981) Long-term management of sustained, recurrent, symptomatic ventricular tachycardia with amiodarone. Circulation 64: 273–279PubMedCrossRefGoogle Scholar
  13. Kastor JA, Horowitz LN, Harken AH, Josephson ME (1981) Clinical electrophysiology of ventricular tachycardia. N Engl J Med 304:1004–1020PubMedCrossRefGoogle Scholar
  14. Kumana C, Hamer J (1979) Anti-arrhythmic drugs. In: Hamer J (ed) Drugs for heart disease. Chapman & Hall, London, pp 44–147Google Scholar
  15. Lichtman J, O’Rourke A, Klein A, Karliner JS (1973) Electrocardiogram of the athlete. Alterations simulating those of organic heart disease. Arch Intern Med 132: 763–770PubMedCrossRefGoogle Scholar
  16. Lie KI, Wellens HJJ, von Capelle FJ, Durrer D (1974) Lidocaine in the prevention of primary ventricular fibrillation. N Engl J Med 29:1324–1326CrossRefGoogle Scholar
  17. Moe GK, Jalife J, Mueller WJ (1977) Reciprocation between pacemaker sites: Re-entrant parasystole? In: Kulbertus HE (ed) Re-entrant arrhythmias. MPT Press, Lancaster, pp 271–280Google Scholar
  18. Nademanee K, Hendrickson JA, Cannom DS, Goldreyer BN, Singh BN (1981) Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone. Am Heart J 101: 759–768PubMedCrossRefGoogle Scholar
  19. Onions CT (ed) (1973) The shorter oxford english dictionary: on historical principles. A-Mark-worthy. Clarendon OxfordGoogle Scholar
  20. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV (1976) Clinical efficacy of Amiodarone as an antiarrhythmic agent. Am J Cardiol 38:934–944PubMedCrossRefGoogle Scholar
  21. Rudolph W, Petri H, Kafka W, Hall D (1979) Effects of propafenon on the accessory pathway (AP) in patients with WPW syndrome (Abstr). Am J Cardiol 43:430Google Scholar
  22. Scheinman MM, Thorburn D, Abbott J A (1975) Use of atropine in patients with acute myocardial infarction and sinus bradycardia. Circulation 52: 627–633PubMedGoogle Scholar
  23. Schwartz PJ, Periri M, Malliani A (1975) The long Q-T syndrome. Am Heart J 89: 378–390PubMedCrossRefGoogle Scholar
  24. Seipel L, Breithardt G (1980) Propafenone — a new antiarrhythmic drug. Eur Heart J 1:309–313PubMedGoogle Scholar
  25. Singh BN, Ellrodt G, Peter CT (1978) Verapamil: A review of its pharmacological properties and therapeutic use. Drugs 15:169–197PubMedCrossRefGoogle Scholar
  26. Tonkin AM, Aylward PE, Joel SE, Heddle WF (1980) Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia. J Cardiovasc Pharmacol 2:473–486PubMedCrossRefGoogle Scholar
  27. Vaughan Williams EM (1978) Some factors that influence the activity of antiarrhythmic drugs. Br Heart J [suppl] 40: 52–61Google Scholar
  28. Waleffe A, Mary-Rabine L, De Rijbel R, Soyeur D, Legrand V, Kulbertus HE (1980) Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia. Eur Heart J 2: 345–352Google Scholar
  29. Wellens HJ (1977) Modes of initiation of circus movement tachycardia in 139 Wolff-Parkinson-White syndrome studied by programmed electrical stimulation. In: Kulbertus HE ed) ReEntrant arrhythmias. MPT Press, Lancaster; pp 135–169Google Scholar
  30. Wit L, Rosen MR (1981 a) Cellular electrophysiology of cardiac arrhythmias, (part 1). Mod Concepts Cardiovasc Dis 50:1–6PubMedGoogle Scholar
  31. Wit AL, Rosen MR (1981 b) Cellular electrophysiology of cardiac arrhythmias, (part 2). Mod Concepts Cardiovasc Dis 2: 7–11Google Scholar
  32. Zilcher H, Glogar D, Kaindl F (1980) Torsades de Pointes: Occurrence in myocardial ischaemia as a separate entity. Multiform ventricular tachycardia or not. Eur Heart J 1: 63–71PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • R. W. F. Campbell

There are no affiliations available

Personalised recommendations